Income Taxes |
9 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Income Tax Disclosure [Abstract] | |
| Income Taxes | Income Taxes The Company’s effective tax rate was 12.6% and 20.6% for the nine months ended June 30, 2026 and 2025, respectively. The most significant items contributing to the difference between the statutory U.S. federal corporate tax rate of 21.0% and the Company’s effective tax rate for the nine-month period ended June 30, 2026 were a tax benefit of $54.7 million related to a net deferred tax asset recognized due to legal entity restructuring, tax benefit of $39.6 million related to income tax credits and incentives, tax expense of $37.5 million related to foreign residual income, and tax expense of $30.2 million related to changes in uncertain tax positions. The tax benefit related to income tax credits and incentives and tax expense related to foreign residual income are expected to have a continuing impact on the effective tax rate for the remainder of the fiscal year. The most significant items contributing to the difference between the statutory U.S. federal corporate tax rate of 21.0% and the Company’s effective tax rate for the nine-month period ended June 30, 2025 were a tax benefit of $47.2 million related to income tax credits and incentives, tax expense of $45.6 million related to foreign residual income, a tax benefit of $20.1 million related to deferred tax assets recognized due to legal entity restructuring, and tax expense of $19.6 million related to state income taxes. During the second quarter of fiscal 2026, the Company recognized a net deferred tax asset of $54.7 million related to legal entity restructuring. The restructuring resulted in the recognition of a deferred tax asset related to tax attributes that are expected to be utilized against future taxable income. During the second quarter of fiscal 2026, the Company recorded a reserve of $34.4 million related to uncertain tax positions associated with certain federal and state tax credits claimed for fiscal 2017 through fiscal 2026. The reserve reflects the Company’s assessment that it is more likely than not that a portion of the credits may not be sustained under examination by the tax authorities based on recent discussions and developments related to our ongoing audits. During the first quarter of fiscal 2025, the Company recognized deferred tax assets of $20.1 million related to legal entity restructuring. The restructuring resulted in the recognition of deferred tax assets related to tax attributes that are expected to be utilized against future taxable income. The Company is utilizing the annual effective tax rate method under ASC 740 to compute its interim tax provision. The Company’s effective tax rate fluctuates from quarter to quarter due to various factors including the change in the mix of global income and expenses, outcomes of administrative audits, changes in the assessment of valuation allowances due to management’s consideration of new positive or negative evidence during the quarter, and changes in enacted tax laws. The U.S. and many international legislative and regulatory bodies have proposed legislation that could significantly impact how our business activities are taxed. These proposed changes could have a material impact on the Company’s income tax expense and deferred tax balances. The Company is currently under tax audit in several jurisdictions including the U.S. where its federal income tax returns for fiscal 2017 through 2020 are being examined by the Internal Revenue Service (IRS). Disputes can arise with tax authorities involving issues related to the timing of deductions, the calculation and use of credits, and the taxation of income in various tax jurisdictions because of differing interpretations or application of tax laws, regulations, and relevant facts. In August 2026, the Company received a draft Notice of Proposed Adjustment (NOPA) from the IRS concerning research and development (R&D) tax credits claimed during fiscal years 2017 through 2020. The draft NOPA proposes adjustments that, if sustained in full, could have a material impact on the Company’s consolidated financial statements. The Company disagrees with the proposed adjustments outlined in the draft NOPA and intends to pursue all available administrative remedies, including filing an appeal. The Company will continue to monitor developments related to the examination and will adjust the reserve as necessary based on changes in facts and circumstances, including the resolution of the audit. Generally, the Company does not provide for U.S. taxes or foreign withholding taxes on gross book-tax differences in its non-U.S. subsidiaries because such basis differences of approximately $1.1 billion are able to and intended to be reinvested indefinitely. If these basis differences were distributed, foreign tax credits could become available under current law to partially or fully reduce the resulting U.S. income tax liability. There may also be additional U.S. or foreign income tax liability upon repatriation, although the calculation of such additional taxes is not practicable.
|